|
|
|
|
|
searchin this issue 
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Displaying 241 - 260 of 414 stories.
December 10, 2007
Contract fine chemicals manufacturer Dottikon Exclusive Synthesis (Dottikon, Switzerland) says that its net income decreased 2.1%, to $5.5 million, in its fiscal first half, ended...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cost-Pressure-Affects-Dottikons-Half-Year-Results_9310.html December 3, 2007
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA; London) has unveiled a new three-year program to combat the sale of counterfeit drugs. The program...http://www.chemweek.com/sections/pharma_and_fine_chemicals/U-K-Unveils-Anti-counterfeit-Drugs-Program_9194.html November 30, 2007
Cambridge Major Laboratories (Germantown, WI), a fine chemicals contract manufacturer, says it has acquired active pharmaceutical ingredients (API) development services company...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cambridge-Major-Buys-European-Development-Services-Firm_9171.html November 30, 2007
A previously disclosed study on the scale of the release of harmful effluents from a wastewater treatment facility in southern India could lead to greater environmental regulations on...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Backlash-in-the-Cards-from-Indian-Plant-Effluent-Study_9172.html November 30, 2007
Pharmaceutical companies Strides Arcolab (Bangalore, India) and Aspen (Durban, South Africa) say they have agreed on a partnership that includes asset swaps. Aspen will buy 50% of...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Strides-Arcolab-South-African-Firm-Agree-on-Assets-Swap_9173.html November 22, 2007
Pharmaceutical company Strides Arcolab (Bangalore, India) and pharmaceuticals firm Aspen (Durban, South Africa) say they have agreed a new partnership that involves swapping assets...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Pharmaceuticals-Strides-Arcolab-and-South-African-Firm-Agree-Assets-Swap_9055.html November 20, 2007
Glenmark Pharmaceuticals (Mumbai) says it plans to hive off its generic drugs and active pharmaceutical ingredient (API) businesses to create a new, wholly owned subsidiary, Glenmark...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Indian-Pharma-Firm-to-Spin-off-Generics-and-Ingredients_8971.html November 20, 2007
The market for biomarkers, a sector with applications in drug discovery, clinical trials, and molecular diagnostics, is growing at a CAGR of 18% and will be worth $5.6 billion in...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Biomarkers-Sector-Slated-for-Rapid-Growth_8972.html November 20, 2007
Cambrex says it will close its North Brunswick, NJ technical center by year-end, and consolidate its U.S. R&D activities and small-scale active pharmaceutical ingredient production...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cambrex-Closes-New-Jersey-Site_8973.html November 20, 2007
Merck & Co. agreed earlier this month to pay a total of $4.85 billion to 47,000 groups of plaintiffs to settle a class-action lawsuit related to Vioxx, Merck’s former...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Merck-and-Co-to-Settle-Vioxx-Claims_8975.html November 16, 2007
Fine chemicals contract manufacturer Cambridge Major Laboratories (Germantown, WI) says it has acquired active pharmaceutical ingredients (API) development services company...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Fine-Chemicals-Cambridge-Major-Buys-ChemShop_8993.html November 12, 2007
The global market for biomarkers, a field that includes biomarker discovery, clinical trials and molecular diagnostics, is growing at an average annual growth rate (CAGR) of 18% and...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Biotechnology-Biomarkers-Market-Slated-for-Rapid-Growth_8854.html November 9, 2007
Dowpharma, Dow Chemical’s business unit that offers services and products to the pharmaceuticals sector, is starting to enjoy commercial success on several fronts for its Pfenex...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Dowpharma-is-Boosted-by-Take-Up-of-Pfenex-Platform_8816.html November 9, 2007
Cambrex reported a 30% hike in third-quarter operating profits, to $3.5 million, on sales up 2.3%, to $54.7 million. The figures relate solely to ongoing businesses. Cambrex sold its...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cambrexs-Third-Quarter-Profits-Rise_8817.html November 9, 2007
Novozymes says it has agreed to acquire Philom Bios (Saskatoon, SK), a manufacturer of proprietary microbial inoculants for the agricultural industry, for approximately C$25.6 million...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Novozymes-to-buy-Canadian-Firm_8818.html November 9, 2007
DSM says that its DSM Ventures subsidiary and private equity firm Capital Resource Partners (CRP; Boston) have each invested in Ganeden Biotech (Mayfield Heights, OH), a manufacturer...http://www.chemweek.com/sections/pharma_and_fine_chemicals/DSM-Invests-in-Probiotics-Startup_8819.html November 9, 2007
Novartis says it will spend about $700 million to build a biopharmaceutical drug manufacturing plant in Singapore. The planned facility will produce monoclonal antibody drugs designed...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Novartis-Plans-Major-Bio-Plant_8820.html November 7, 2007
Rhodia says it will cease production of paracetamol at its Roussillon, France plant by the end of 2008. Closing the plant will result in 43 job losses. Rhodia has another site for...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Rhodia-Closes-French-Paracetamol-Plant-Citing-Tough-Competition_8738.html November 7, 2007
BASF plans to “ramp up” spending to develop diagnostic and prognostic test products designed by its Metanomics Health (Berlin) human health biotechnology business, said...http://www.chemweek.com/sections/pharma_and_fine_chemicals/BASF-Plans-to-Ramp-Up-R-and-D-Spending_8739.html November 7, 2007
Pharmaceutical company Strides Arcolab (Bangalore, India) says it has agreed on a deal with pharma manufacturer Sagent Pharmaceuticals (Schaumburg, IL) to jointly develop, supply, and...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Strides-Agrees-on-Injectables-Deal_8740.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
